Fund Holdings — Samsara BioCapital, LLC

Total Portfolio Value:
$488.95M
Total Bought:
$17.52M
Total Sold:
$46.71M
Net Transaction:
-$29.19M
Notable People:
Michael Philip Dybbs
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Scholar Rock Holding Corporation(SRRK)5,612,8965,612,8960$180.45M$198.81M40.66%+$18.35M
Mineralys Therapeutics, Inc.(MLYS)5,674,9165,674,9160$90.12M$76.78M15.70%-$13.34M
Septerna, Inc.(SEPN)3,149,1283,149,1280$18.23M$33.29M6.81%+$15.05M
Kalaris Therapeutics, Inc.(KLRS)11,448,08111,448,0810$91.93M$30.57M6.25%-$61.36M
Neurogene Inc.(NGNE)1,717,1271,717,1270$20.11M$25.67M5.25%+$5.56M
Cargo Therapeutics Inc4,415,6894,415,6890$17.97M$18.19M3.72%+$220.8K
Upstream Bio, Inc.(UPB)2,067,1461,443,231-623,915$12.65M$15.85M3.24%+$3.20M
Alumis Inc3,266,4984,801,370+1,534,872$20.06M$14.40M2.95%-$5.65M
LENZ Therapeutics, Inc.(LENZ)526,390343,012-183,378$13.53M$10.05M2.06%-$3.48M
Palvella Therapeutics, Inc.(PVLA)679,486339,743-339,743$19.02M$7.66M1.57%-$11.36M
Gossamer Bio, Inc.(GOSS)6,130,2686,130,2680$6.74M$7.54M1.54%+$796.9K
Arcellx Inc
COMMON STOCK
135,276101,457-33,819$8.87M$6.68M1.37%-$2.19M
Aura Biosciences, Inc.(AURA)01,000,000+1,000,000$0$6.26M1.28%+$6.26M
Nkarta, Inc.(NKTX)3,768,0353,768,0350$6.93M$6.25M1.28%-$678.2K
Avadel Pharmaceuticals Plc967,527675,504-292,023$7.58M$5.98M1.22%-$1.60M
Jade Biosciences Inc0531,163+531,163$0$5.31M1.09%+$5.31M
Zymeworks Inc.(ZYME)666,667310,300-356,367$7.94M$3.89M0.80%-$4.05M
Rhythm Pharmaceuticals, Inc.(RYTM)138,11850,476-87,642$7.32M$3.19M0.65%-$4.13M
vTv Therapeutics Inc.CL A(VTVT)206,784206,7840$3.58M$3.10M0.63%-$479.7K
Contineum Therapeutics, Inc.CL A(CTNM)588,816588,8160$4.11M$2.34M0.48%-$1.77M
Surrozen, Inc.(SRZN)241,400241,4000$2.81M$2.16M0.44%-$656.6K
Sutro Biopharma, Inc.(STRO)2,196,8142,196,8140$1.43M$1.57M0.32%+$139.1K
Tango Therapeutics, Inc.(TNGX)630,000210,000-420,000$863.1K$1.08M0.22%+$212.1K
Hillevax Inc399,637399,6370$579.5K$795.3K0.16%+$215.8K
Terns Pharmaceuticals Inc202,348202,3480$558.5K$754.8K0.15%+$196.3K
Artiva Biotherapeutics, Inc.(ARTV)291,666291,6660$875.0K$440.4K0.09%-$434.6K
Bolt Biotherapeutics Inc052,456+52,456$0$302.7K0.06%+$302.7K
Nuvation Bio Inc.W EXP 02 10 202(NUVB)133,333133,3330$42.7K$36.0K0.01%-$6.7K
Surrozen, Inc.W EXP 08 01 203(SRZN)99,99999,9990$3.0K$1.8K0.00%-$1.2K
ABIVAX Société AnonymeADS(ABVX)425,0000-425,000$2.66M$0—-$2.66M
Acelyrin Inc2,523,0220-2,523,022$6.23M$0—-$6.23M
Allakos Inc172,0890-172,089$39.2K$0—-$39.2K
Bolt Biotherapeutics Inc1,049,1530-1,049,153$419.7K$0—-$419.7K
Curis, Inc.(CRIS)185,9430-185,943$390.5K$0—-$390.5K
Inozyme Pharma Inc1,562,5000-1,562,500$1.42M$0—-$1.42M
Kronos Bio Inc78,1310-78,131$64.5K$0—-$64.5K
Cypherpunk Technologies Inc.(CYPH)2,442,3520-2,442,352$745.2K$0—-$745.2K
Lyra Therapeutics Inc1,390,1300-1,390,130$175.6K$0—-$175.6K
OnKure Therapeutics, Inc.CL A(OKUR)824,1550-824,155$3.54M$0—-$3.54M
Prime Medicine, Inc.(PRME)405,2280-405,228$806.4K$0—-$806.4K
Page 1 of 1
Samsara BioCapital, LLC — 13F Holdings — Q2 2025 | TickerTrail